StockDrifts LogoStockDrifts

Act Capital Management 13F Portfolio

Portfolio Manager
Act Capital Management LLC
Performance
+14.26% (2026 Q2)
AUM (13F)
$153.06M
# of Holdings
62
Performance Rank
N/A
Allocation (Top 20)
84.95%
Latest filing
Q2 2026

Act Capital Management LLC Holdings Map

Top 50 Act Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
KRYS
KRYSTAL BIOTECH INC
10.93%45.0K$16.7M
-25.59%(-15.48K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 60.5K shares2026-Q1: 60.5K shares2026-Q2: 45.0K shares
$211.53(+54.77%)
2026-06-30
TGTX
TG THERAPEUTICS INC
9.01%251.0K$13.8M
+0.80%(+2.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 268.9K shares2026-Q1: 249.0K shares2026-Q2: 251.0K shares
$33.05(+51.62%)
2026-06-30
ABVX
ABIVAX SA
8.44%97.0K$12.9M
+36.81%(+26.10K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 63.9K shares2026-Q1: 70.9K shares2026-Q2: 97.0K shares
$112.85(+12.59%)
2026-06-30
CVX
CHEVRON CORP
8.12%75.0K$12.4M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 78.5K shares2026-Q1: 75.0K shares2026-Q2: 75.0K shares
$153.85(+26.71%)
2026-06-30
XOM
EXXON MOBIL CORP
7.01%78.5K$10.7M
+12.14%(+8.50K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 82.5K shares2026-Q1: 70.0K shares2026-Q2: 78.5K shares
$120.61(+32.45%)
2026-06-30
ARWR
ARROWHEAD PHARMACEUTICALS INC
5.86%110.1K$9.0M
+33.45%(+27.60K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 75.0K shares2026-Q1: 82.5K shares2026-Q2: 110.1K shares
$56.20(+59.50%)
2026-06-30
VKTX
VIKING THERAPEUTICS INC
5.33%209.3K$8.2M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 206.1K shares2026-Q1: 209.3K shares2026-Q2: 209.3K shares
$30.78(+11.95%)
2026-06-30
CELC
CELCUITY INC
4.25%62.1K$6.5M
-32.21%(-29.52K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 63.4K shares2026-Q1: 91.7K shares2026-Q2: 62.1K shares
$84.55(+7.41%)
2026-06-30
NKTR
NEKTAR THERAPEUTICS
4.07%89.3K$6.2M
+25.95%(+18.40K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 51.2K shares2026-Q1: 70.9K shares2026-Q2: 89.3K shares
$54.95(+35.91%)
2026-06-30
TSLA
TESLA INC
2.97%10.8K$4.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 10.8K shares
$387.94(-14.46%)
2026-06-30

About Act Capital Management LLCโ€™s portfolio

Act Capital Management LLC reports $153.06M in US-listed equity holdings across 62 positions in its most recent 13F filing. Its largest disclosed positions are KRYS (10.9%), TGTX (9.0%) and ABVX (8.4%). The top 20 holdings account for 84.95% of reported assets. Its disclosed equity book has returned -43.12% cumulatively over 8 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
KRYS โ€” 11.2% ($16.73M)TGTX โ€” 9.2% ($13.79M)ABVX โ€” 8.6% ($12.93M)CVX โ€” 8.3% ($12.43M)XOM โ€” 7.2% ($10.73M)ARWR โ€” 6.0% ($8.97M)VKTX โ€” 5.5% ($8.16M)CELC โ€” 4.3% ($6.50M)NKTR โ€” 4.2% ($6.23M)TSLA โ€” 3.0% ($4.54M)Other โ€” 32.4% ($48.52M)
68%in top 10
  • KRYS11.2%
  • TGTX9.2%
  • ABVX8.6%
  • CVX8.3%
  • XOM7.2%
  • ARWR6.0%
  • VKTX5.5%
  • CELC4.3%
  • NKTR4.2%
  • TSLA3.0%
  • Other32.4%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
15
TSLATESLA INC3.0%
ASTSAST SPACEMOBILE INC2.5%
PVLAPALVELLA THERAPEUTICS INC2.3%
NBISNEBIUS GROUP NV1.2%
+11 opened
Added to
14
ABVXABIVAX SA+36.8%
ARWRARROWHEAD PHARMACEUTICALS INC+33.5%
NUVBNUVATION BIO INC+79.3%
NKTRNEKTAR THERAPEUTICS+26.0%
+10 more
Trimmed
10
KRYSKRYSTAL BIOTECH INC-25.6%
AMZNAMAZON.COM INC-60.9%
ALMSALUMIS INC-70.4%
CELCCELCUITY INC-32.2%
+6 more

Unlock alerts, watchlists & AI chat

Sign up free to track Act Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Act Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1442273). View Act Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all